Galmed Pharmaceuticals (GLMD) Capital Expenditures (QoQ) (2013 - 2023)
Galmed Pharmaceuticals (GLMD) Capital Expenditures (QoQ) (2013 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2023 |
-157.14% |
| Jun 30, 2022 |
-100.00% |
| Mar 31, 2022 |
-104.76% |
| Dec 31, 2021 |
1,150.00% |
| Sep 30, 2021 |
71.43% |
| Jun 30, 2021 |
-600.00% |
| Mar 31, 2021 |
-101.30% |
| Dec 31, 2020 |
375.00% |
| Dec 31, 2019 |
40.00% |
| Mar 31, 2019 |
89.19% |
| Dec 31, 2018 |
28.85% |
| Mar 31, 2018 |
50.00% |
| Dec 31, 2017 |
0.00% |
| Sep 30, 2017 |
-100.00% |
| Jun 30, 2017 |
85.71% |
| Mar 31, 2017 |
-177.78% |
| Dec 31, 2016 |
400.00% |
| Sep 30, 2016 |
80.00% |
| Jun 30, 2016 |
-87.50% |
| Sep 30, 2015 |
96.05% |
